Skip to search.
 TSX Up 0.60% TSX Ventures Up 1.02%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
553.66 Up 6.56(1.20%) Jul 31, 4:00PM EDT
|After Hours : 554.00 Up 0.34 (0.06%) Jul 31, 6:42PM EDT
Add to Portfolio
Prev Close:547.10
Open:551.29
Bid:550.32 x 100
Ask:N/A
1y Target Est:530.13
Beta:1.03
Next Earnings Date: 4-Aug-15REGN Earnings announcement
Day's Range:547.85 - 558.50
52wk Range:314.00 - 569.91
Volume:501,079
Avg Vol (3m):722,645
Market Cap:58.27B
P/E (ttm):177.63
EPS (ttm):3.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
REGNUp 1.20%58.27B
AMGNUp 2.85%134.27B
NVSUp 0.55%250.57B
RHHBYUp 0.17%245.91B

Key Statistics

Forward P/E (1 yr):40.53
P/S (ttm):18.26
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :11.15
Quarterly EPS Est (Jun-15) :2.77
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):2.30

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback